Drug Supply Chain Security Act (DSCSA) Transaction Report (T3)

Transaction Report T3

This post is Part 2 of the Series: Understanding The Drug Supply Chain Security Act and What it Means for Pharmaceutical Distribution Companies. For a full list of all the topics in this series, please see the bullet points at the end of this post.  2024 Update: Blue Link has reviewed various FDA communications and … Read more

Drug Supply Chain Security Act (DSCSA) and Pharmaceutical Distribution

Drug Supply Chain Security Act

This post is Part 1 of the Series: Understanding The Drug Supply Chain Security Act and What it Means for Pharmaceutical Distribution Companies.   The Drug Supply Chain Security Act (DSCSA) was written in an attempt to provide guidance to the pharmaceutical industry relating to the traceability of pharmaceutical products in the supply chain. The … Read more

The DSCSA and my Pharmaceutical Distribution Business

The DSCSA and your Pharmaceutical business

The Drug Supply Chain Security Act (DSCSA) was signed into legislation by US President Barack Obama on November 27, 2013, ushering in a new age of transparency and accountability in the pharmaceutical industry. The DSCSA outlines several phases aimed at establishing an interconnected platform that will successfully identify and trace specific prescription drugs as they … Read more